DE69025920D1 - Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten - Google Patents
Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthaltenInfo
- Publication number
- DE69025920D1 DE69025920D1 DE69025920T DE69025920T DE69025920D1 DE 69025920 D1 DE69025920 D1 DE 69025920D1 DE 69025920 T DE69025920 T DE 69025920T DE 69025920 T DE69025920 T DE 69025920T DE 69025920 D1 DE69025920 D1 DE 69025920D1
- Authority
- DE
- Germany
- Prior art keywords
- glycosaminoglycan
- preparation
- modified protein
- pharmaceutical preparations
- preparations containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 1
- 125000003172 aldehyde group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 230000001766 physiological effect Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2081163A JP2975632B2 (ja) | 1990-03-30 | 1990-03-30 | グリコサミノグリカン修飾プロテイン |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69025920D1 true DE69025920D1 (de) | 1996-04-18 |
DE69025920T2 DE69025920T2 (de) | 1996-08-14 |
Family
ID=13738789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69025920T Expired - Fee Related DE69025920T2 (de) | 1990-03-30 | 1990-10-12 | Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten |
Country Status (12)
Country | Link |
---|---|
US (1) | US5310881A (de) |
EP (1) | EP0454898B1 (de) |
JP (1) | JP2975632B2 (de) |
KR (1) | KR100188382B1 (de) |
AT (1) | ATE135375T1 (de) |
AU (1) | AU649416B2 (de) |
CA (1) | CA2027447A1 (de) |
DE (1) | DE69025920T2 (de) |
DK (1) | DK0454898T3 (de) |
ES (1) | ES2083989T3 (de) |
FI (1) | FI102836B (de) |
NO (1) | NO179044C (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0502550B1 (de) * | 1991-03-07 | 1995-01-04 | Mect Corporation | Colominsäure und Produkte einer teilweisen Hydrolyse von Colominsäure zur Herstellung von Arzneimitteln zur Behandlung von Hepatitis, Nephritis und Arthritis |
US5846951A (en) * | 1991-06-06 | 1998-12-08 | The School Of Pharmacy, University Of London | Pharmaceutical compositions |
GB9112212D0 (en) * | 1991-06-06 | 1991-07-24 | Gregoriadis Gregory | Pharmaceutical compositions |
GB2266239B (en) * | 1992-03-25 | 1996-03-06 | Jevco Ltd | Wound healing compositions containing chondroitin sulphate oligosaccharides |
CA2091544A1 (en) * | 1992-03-26 | 1993-09-27 | Shing F. Kwan | Stabilization of functional proteins |
EP0744409B9 (de) * | 1994-02-23 | 2009-08-19 | Kyowa Hakko Kogyo Co., Ltd | Beschleuniger des plättchenwachstums |
JPH09503001A (ja) * | 1994-05-09 | 1997-03-25 | ベーリンガー マンハイム ゲゼルシャフト ミット ベシュレンクテル ハフツング | ニューロンを保護するためのコンドロイチン硫酸プロテオグリカンの使用 |
US6228998B1 (en) | 1994-07-22 | 2001-05-08 | Seikagaku Kogyo Kabushiki Kaisha | Amino spacered glycosaminoglycan derivatives and their use in copolymerization with acrylamide |
US5912000A (en) * | 1994-09-23 | 1999-06-15 | Zonagen, Inc. | Chitosan induced immunopotentiation |
WO1996009805A2 (en) * | 1994-09-23 | 1996-04-04 | Zonagen, Inc. | Chitosan induced immunopotentiation |
US5677276A (en) * | 1994-12-23 | 1997-10-14 | La Jolla Cancer Research Foundation | Immobilization of peptides to hyaluronate |
RU2176509C2 (ru) * | 1995-09-19 | 2001-12-10 | Сейкагаку Корпорейшн | Средство, усиливающее противовоспалительное действие иммунодепрессанта (варианты), способ усиления противовоспалительного действия иммунодепрессанта, способ лечения воспаления |
US6562781B1 (en) | 1995-11-30 | 2003-05-13 | Hamilton Civic Hospitals Research Development Inc. | Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
US6491965B1 (en) | 1995-11-30 | 2002-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
US7045585B2 (en) * | 1995-11-30 | 2006-05-16 | Hamilton Civic Hospital Research Development Inc. | Methods of coating a device using anti-thrombin heparin |
CA2266747A1 (en) * | 1996-09-25 | 1998-04-02 | Mary Ann Childs | Diagnostic test devices with improved fluid movement and resistance to interferences |
WO2001005434A2 (en) * | 1999-07-20 | 2001-01-25 | Amgen Inc. | Hyaluronic acid-protein conjugates |
EP2298354B1 (de) * | 2001-10-10 | 2014-03-19 | ratiopharm GmbH | Neumodulierung und Glykokonjugation von Interferon-beta |
EP2292271A3 (de) * | 2001-10-10 | 2011-09-14 | BioGeneriX AG | Neumodulierung und Glykokonjugation von Antikörpern |
DE10209822A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
DE10209821A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
WO2004024776A1 (en) | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | Method of producing hydroxyalkyl starch derivatives |
US7862831B2 (en) * | 2002-10-09 | 2011-01-04 | Synthasome, Inc. | Method and material for enhanced tissue-biomaterial integration |
EP1558216A4 (de) * | 2002-09-25 | 2007-01-03 | Univ Johns Hopkins Med | Vernetzte polymermatrizen und herstellungs-und anwendungsverfahren dafür |
US8673333B2 (en) * | 2002-09-25 | 2014-03-18 | The Johns Hopkins University | Cross-linked polymer matrices, and methods of making and using same |
WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
US7807824B2 (en) | 2003-08-12 | 2010-10-05 | Lipoxen Technologies Limited | Sialic acid derivatives for protein derivatisation and conjugation |
WO2006089119A2 (en) * | 2005-02-18 | 2006-08-24 | Cartilix, Inc. | Biological adhesive |
WO2006090119A1 (en) | 2005-02-23 | 2006-08-31 | Lipoxen Technologies Limited | Activated sialic acid derivatives for protein derivatisation and conjugation |
EP1886696A1 (de) * | 2006-08-03 | 2008-02-13 | Endotis Pharma | Konjugate von antithrombin-bindende-oligosaccharid-derivate und therapeutische proteine |
WO2012170504A2 (en) * | 2011-06-06 | 2012-12-13 | The Cleveland Clinic Foundation | Treatment of extracellular matrix to reduce inflammation |
WO2015046602A1 (ja) | 2013-09-30 | 2015-04-02 | 生化学工業株式会社 | タンパク質の血中滞留性の増強方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2824092A (en) * | 1955-01-04 | 1958-02-18 | Robert E Thompson | Process of preparation of a gelatincarboxymethyl cellulose complex |
GB1479268A (en) * | 1973-07-05 | 1977-07-13 | Beecham Group Ltd | Pharmaceutical compositions |
US4301153A (en) * | 1977-03-21 | 1981-11-17 | Riker Laboratories, Inc. | Heparin preparation |
CA1171375A (en) * | 1980-09-15 | 1984-07-24 | Ulf P.F. Lindahl | Oligosaccharides having selective anticoagulation activity |
US4356170A (en) * | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
US4526714A (en) * | 1982-12-13 | 1985-07-02 | Cordis Europa N.V. | Conjugates of anticoagulant and protein |
NL188622C (nl) * | 1981-12-15 | 1992-08-17 | Cordis Europ | Werkwijze ter verbetering van de bloedcompatibiliteit van een materiaaloppervlak door bekleding daarvan met een heparine of heparine-analoga en een eiwit houdende film, alsmede voorwerp, omvattende een oppervlak met verbeterde bloedcompatibiliteit verkregen onder toepassing van een op het oppervlak aangebrachte heparine of heparine-analoga en een eiwit houdende film. |
SE8200751L (sv) * | 1982-02-09 | 1983-08-10 | Olle Larm | Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter |
US4585754A (en) * | 1984-01-09 | 1986-04-29 | Valcor Scientific, Ltd. | Stabilization of proteins and peptides by chemical binding with chondroitin |
US4863907A (en) * | 1984-06-29 | 1989-09-05 | Seikagaku Kogyo Co., Ltd. | Crosslinked glycosaminoglycans and their use |
DE3680524D1 (de) * | 1986-04-22 | 1991-08-29 | Valcor Scient Ltd | Verfahren zur stabilisierung von proteinen. |
US4745180A (en) * | 1986-06-27 | 1988-05-17 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using heparin fragments |
DE3636590A1 (de) * | 1986-10-28 | 1988-05-26 | Braun Melsungen Ag | Blutersatzmittel |
FR2631970B1 (fr) * | 1988-05-24 | 1993-12-24 | Sanofi | N-polyosyl-polypeptides |
DE3819079A1 (de) * | 1988-06-04 | 1989-12-07 | Hoechst Ag | Hirudin-derivate mit verzoegerter wirkung |
WO1990001332A1 (en) * | 1988-08-10 | 1990-02-22 | Cetus Corporation | Plasminogen activator-heparin conjugates |
-
1990
- 1990-03-30 JP JP2081163A patent/JP2975632B2/ja not_active Expired - Lifetime
- 1990-10-10 NO NO904378A patent/NO179044C/no unknown
- 1990-10-10 AU AU64506/90A patent/AU649416B2/en not_active Ceased
- 1990-10-11 FI FI905003A patent/FI102836B/fi not_active IP Right Cessation
- 1990-10-12 AT AT90119607T patent/ATE135375T1/de active
- 1990-10-12 KR KR1019900016160A patent/KR100188382B1/ko not_active IP Right Cessation
- 1990-10-12 DK DK90119607.1T patent/DK0454898T3/da active
- 1990-10-12 CA CA002027447A patent/CA2027447A1/en not_active Abandoned
- 1990-10-12 DE DE69025920T patent/DE69025920T2/de not_active Expired - Fee Related
- 1990-10-12 ES ES90119607T patent/ES2083989T3/es not_active Expired - Lifetime
- 1990-10-12 EP EP90119607A patent/EP0454898B1/de not_active Expired - Lifetime
-
1992
- 1992-07-02 US US07/908,910 patent/US5310881A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2083989T3 (es) | 1996-05-01 |
FI905003A (fi) | 1991-10-01 |
DE69025920T2 (de) | 1996-08-14 |
ATE135375T1 (de) | 1996-03-15 |
EP0454898A1 (de) | 1991-11-06 |
FI102836B1 (fi) | 1999-02-26 |
NO179044C (no) | 1996-07-24 |
NO904378D0 (no) | 1990-10-10 |
FI102836B (fi) | 1999-02-26 |
JPH03284698A (ja) | 1991-12-16 |
US5310881A (en) | 1994-05-10 |
NO179044B (no) | 1996-04-15 |
CA2027447A1 (en) | 1991-10-01 |
DK0454898T3 (da) | 1996-04-15 |
KR100188382B1 (ko) | 1999-06-01 |
KR910016770A (ko) | 1991-11-05 |
NO904378L (no) | 1991-10-01 |
AU6450690A (en) | 1991-10-31 |
AU649416B2 (en) | 1994-05-26 |
EP0454898B1 (de) | 1996-03-13 |
FI905003A0 (fi) | 1990-10-11 |
JP2975632B2 (ja) | 1999-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69025920D1 (de) | Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten | |
YU174490A (sh) | Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja | |
ATE49886T1 (de) | Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung. | |
DE3851986D1 (de) | Aminsäure-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen. | |
ATE121089T1 (de) | Optisch aktives 5h-pyrrolo(3,4-b>pyrazinderivat, seine herstellung und pharmazeutische zubereitungen die es enthalten. | |
DE3584120D1 (de) | Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
DE68903442T2 (de) | Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung. | |
DE68923819D1 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
DE3852145D1 (de) | Indolderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten. | |
DE3783356D1 (de) | Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
DE68909412D1 (de) | Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen. | |
ATE56956T1 (de) | (s)-(-)-1-propyl-2',6'-pipecoloxylididhydrochloridmonohydrat, verfahren zu seiner herstellung und es enthaltendes pharmazeutisches praeparat. | |
DE3887068D1 (de) | 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen. | |
ATE58538T1 (de) | 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
DE3868309D1 (de) | Imidazol-derivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammenstellungen und deren anwendung als arzneimittel. | |
ATE57935T1 (de) | 16,17-acetalsubstituierte pregnan-21-saeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate. | |
ATE106883T1 (de) | Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten. | |
ATE58293T1 (de) | Heterocyclische disulfide, verfahren zu ihrer herstellung und pharmazeutische mittel, die diese verbindungen enthalten. | |
ATE61222T1 (de) | Aspoxicillin enthaltende medizinalzubereitung, ein verfahren zu ihrer herstellung und ihre verwendung zur herstellung eines arzneimittels. | |
ATE39697T1 (de) | Erythromycin-a-salz mit mucosecretolytischer und fluidisierender aktivitaet, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen. | |
ATE94883T1 (de) | Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen. | |
ATE41418T1 (de) | S-(carbamoyl-phenylselenyl)-derivate des glutathions und von aminomercaptocarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
ATE53384T1 (de) | 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten. | |
ATE82280T1 (de) | Imidazol-derivate, verfahren zu ihrer herstellung, pharmazeutische zubereitungen, welche diese enthalten, verwendung dieser zur herstellung therapeutisch wirksamer arzneimittel und zwischenprodukte, welche beim herstellungsverfahren entstehen. | |
HUT64950A (en) | Diagnostic preparations and process for producing aminopolycarboxylic acides and their metalchelates as well as pharmaceutical preparations having such active ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |